Dr. Hamed Mirzaei’s research is focused on finding the target of novel and FDA approved compounds using a combination of proteomics, computational biology and biochemistry. Many FDA approved drugs are in use without clear understanding of their mechanism of action. There are quite a few well-characterized natural products with unknown targets. Dr. Mirzaei uses systems pharmacology to understand the drug’s mechanism of action by identifying the target of the drugs and their cellular and organismal phenotypes.